Skip to main content

New information on resveratrol’s breast cancer fighting properties

There is hardly a stickier subject than alcohol consumption and breast cancer, except perhaps the wildly exaggerated claims for resveratrol supplements. A new study helps to clarify the picture by looking at resveratrol’s interaction with estrogen receptors on breast cancer cells, though we still have a ways to go before resveratrol can be recommended for duty in the breast cancer battle.


Some historical context will help put things into perspective. Most studies have concluded that breast cancer risk is increased by alcohol consumption, though the effect at moderate drinking levels is a very difficult thing to measure. On the other hand, it is well-documented that moderate regular consumption of wine is associated with longer life and lower rates of diseases such as cancer, diabetes, atherosclerosis, and Alzheimer’s. Though red wine contains a number of antioxidant molecules, resveratrol has emerged as one of the more interesting ones despite that fact that wine doesn’t actually have very much of it. Nevertheless, resveratrol is touted as the explanation for the French paradox and an anti-aging miracle. So more sober-minded scientists can be forgiven a bit of cynicism here.

Resveratrol does do some very interesting things though, at least in laboratory studies. One vein of research follows the observation that wine drinkers tend to have lower rates of osteoporosis. This it turns out is explained by resveratrol’s estrogen-like properties. Tied with an impressive array of specific anti-cancer effects (again, in lab studies not clinical trials) it seems that something must be going on with resveratrol and breast cancer. But since many breast cancers are “estrogen receptor positive” (ER+) meaning that too much estrogen could encourage cancer growth, it is important to know the details.

This recent study helps to sort that out, by looking specifically at ER+ cancer cells. What the researchers found was that resveratrol appeared to turn off the gene that makes estrogen receptors, reducing the number of receptors in the cells and ramping down cell growth. Combined with non-ER-related cancer fighting properties, resveratrol or its derivatives could very well be useful in fighting breast cancer. The road to effective cancer treatments is littered with false starts and dead ends, however, so the smart money will wait for clinical trial data.

Comments

  1. This is a really good read for me. Must agree that you are one of the coolest bloggers I ever saw. Thanks for posting this informative article.
    Chemotherapy Treatments

    ReplyDelete
  2. I just now wanted to tell you how much we appreciate almost everything you’ve provided to help improve lives of individuals in this subject matter. Through your own articles, I’ve really gone from just an inexperienced to a specialist in the area. It’s truly a homage to your work. Thanks gout relief

    ReplyDelete

Post a Comment

Popular posts from this blog

Revisiting resveratrol: new findings rekindle anti-aging debate

Just when we thought the bloom was off the rosé for resveratrol, the anti-oxidant polyphenol from red wine with multiple anti-aging properties, along comes new research giving life to the debate. But first a bit of background: As I detailed in my book Age Gets Better with Wine , it is well-documented that wine drinkers live longer and have lower rates of many diseases of aging. Much or the credit for this has been given to resveratrol, though there isn’t nearly enough of it in wine to explain the effects. Nevertheless, I dubbed it the “miracle molecule” and when it was reported to activate a unique life-extension phenomenon via a genetic trigger called SIRT, an industry was born, led by Sirtris Pharmaceuticals, quickly acquired by pharma giant Glaxo. The hope was that resveratrol science could lead to compounds enabling people to live up to 150 years and with a good quality of life. But alas, researchers from other labs could not duplicate the results, and clinical studies disa...

Should wine labels make health claims?

Winemakers have been in a debate for some years now with the U.S. Department of Treasury's Alcohol, Tax and Trade Bureau (formerly the ATF, for Alcohol, Tobacco, and Firearms--yeah, that made a lot of sense) about ingredient listing for wines, particularly since the healthful properties of wine polyphenols such as resveratrol have been widely publicised. A couple of years back, an Oregon pinot noir producer gained approval for a fairly benign claim: "Pinot noir develops a natural defense against botrytis (mold) in our moist, cool climate - the antioxidant resveratrol." Since resveratrol is indeed produced in the skins of grapes subjected to certain environmental stresses such as mold, and Oregon's climate is certifiably moist, it seems a fairly harmless claim. However, the feds simultaneously disallowed placing the same wording on another vintage from the same producer, citing concern about making therapeutic claims on labels or creating "misleading" associa...